SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Merck
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
1580 80 0 MRK
Emcee:  Alfred W. Post Type:  Unmoderated
Introduction Market Data Compact
The stock has done quite nicely but lately it has put in the reverse gear. Does anybody know why? Is is for fear that Hillary might get her husband to reinact the healthcare reform? As far as I know, the pipeline of new products is nicely filled - so what is going on? Any information would be greatly appreciated from Alfred W. Post in Switzerland
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1580 Merck Signs Sale Agreement with Santen for Merck's OphthalmologySavant15/13/2014
1579 UPDATE: FDA approves Merck's heart-attack prevention drug **(noSavant-5/13/2014
1578true, but loving it.mopgcw-5/2/2014
1577thread is dead; stock isn't.hdl-4/29/2014
1576Come join the discussion on siliconinvestor.com , where MRK receives its share oDewDiligence_on_SI-1/30/2014
1575yep, but thankfully the stock isn't. it has been a great vehicle to own/tramopgcw-1/30/2014
1574this thread is dead.hdl-1/30/2014
1573UPDATE 2-Merck stops giving clot drug in study, shares drop 10:20 am ET 01/13/20mopgcw-1/13/2011
1572#msg-26732685DewDiligence_on_SI-8/4/2010
1571Merck Reports Encouraging Results for Hepatitis C By PETER LOFTUS Merck &mopgcw-8/4/2010
1570There’s some serious spin in this write-up, IMO, about the collaboration with AGDewDiligence_on_SI-2/1/2010
1569xconomy: Merck’s Alan Sachs, on RNAi’s Big Challenge: Delivery, Delivery, Delivemopgcw-1/31/2010
1568CS: We have incorporated information from this morning's conference call relmopgcw-12/5/2008
1567Forbes: Another pharmaceutical company in trouble is Merck (nyse: MRK - news - pmopgcw-11/4/2008
1566<b>Merck And The Shrinking Drug Industry</b> forbes.com Matthew Heidos-10/23/2008
1565CS Merck & Co. (MRK) Neutral C. Arnold CP: US$ 35.33 TP: US$ 40 CAP: US$ 75.mopgcw-7/22/2008
1564Drugs to Build Bones May Weaken Them Well By TARA PARKER-POPE Published: July Doc Bones-7/15/2008
1563Merck’s Clark on PR Woes: ‘I Can’t Blame the Media’ Posted by Peter Loftus MayDoc Bones-5/2/2008
1562Cramer: Message 24485097Doc Bones-4/10/2008
1561GS: What's changed Given the ENHANCE data presented at the ACC meeting this mopgcw-4/1/2008
1560Please explain: 1 Is there a difference between HIV-1 and regualar HIV? 2 WhatCarey Thompson-3/30/2008
1559Isentress has a relatively narrow FDA label: <i>“In combination with othDewDiligence_on_SI-3/30/2008
1558Update on MK 518. I received my Annual Report from Merck this week, and to myCarey Thompson-3/30/2008
1557Possible Suicide Link Prompts FDA to Probe Merck Asthma Drug By JENNIFER CORBDoc Bones-3/28/2008
1556Addex and Merck & Co., Inc. Enter License Agreement to Develop a Drug Candidnigel bates-1/3/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News